Preliminary pharmacokinetics of the bacterial virulence inhibitor N′-(3,5-Dibromo-2-Hydroxy-Benzylidenene)-Nicotinic acid hydrazide

Advances in Experimental Medicine and Biology

Volumn 954, Issue , 2012, Pages 349-356

  Ur Rehman, Tofeeq ^a,b   Nordfelth, Roland ^a   Blomgren, Anders ^c,d   Zetterström, Caroline E ^a   Elofsson, Mikael ^a   Gylfe, Åsa ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c ASTRAZENECA R AND D   (Sweden)

^d Clinical Chemistry Lund   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HYDRAZINE DERIVATIVE; N' (3,5 DIBROMO 2 HYDROXY BENZYLIDENENE)NICOTINIC ACID HYDRAZIDE; N'-(3,5-DIBROMO-2-HYDROXY-BENZYLIDENENE)NICOTINIC ACID HYDRAZIDE; NICOTINIC ACID DERIVATIVE;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECT; MOUSE; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG RESISTANCE, BACTERIAL; HYDRAZINES; MICE; MICE, INBRED BALB C; NICOTINIC ACIDS; VIRULENCE;

EID: 84868160252     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3561-7_42     Document Type: Conference Paper

References (16)

1. Bailey L, Gylfe A, Sundin C et al (2007) Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett 581:587-595
2. Chu H, Slepenkin A, Elofsson M et al (2010) Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae. Int J Antimicrob Agents 36:145-150
3. Dahlgren MK, Zetterström CE, Gylfe A et al (2010) Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg Med Chem 18:2686-2703
4. Dumortier G, Grossiord JL, Agnely F et al (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709-2728
5. Hudson DL, Layton AN, Field TR et al (2007) Inhibition of type III secretion in Salmonella enterica serovar typhimurium by small-molecule inhibitors. Antimicrob Agents Chemother 51:2631-2635
6. Kauppi AM, Nordfelth R, Uvell H et al (2003) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10:241-249
7. Keyser P, Elofsson M, Rosell S et al (2008) Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med 264:17-29
8. Lee YC, Zocharski PD, Samas B (2003) An intravenous formulation decision tree for discovery compound formulation development. Int J Pharm 253:111-119
9. Liu Y, Zhu YY, Wei G, Lu WY, (2009) Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties. Eur J Pharm Sci 37:306-312
10. Muschiol S, Bailey L, Gylfe A et al (2006) A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 103:14566-14571
11. Negrea A, Bjur E, Ygberg SE et al (2007) Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 51:2867-2876
12. Nordfelth R, Kauppi AM, Norberg HA et al (2005) Smallmolecule inhibitors speci fi cally targeting type III secretion. Infect Immun 73:3104-3114
13. Schmolka IR (1972) Arti fi cial skin: I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 6:571-582
14. Singh-Joy SD, McLain VC (2008) Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 27(suppl 2):93-128
15. Tree JJ, Wang D, McInally C et al (2009) Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect Immun 77:4209-4220
16. Zhang Y, Huo M, Zhou J et al (2010) PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99:306-314